Dina Chaya's most recent trade in Spruce Biosciences Inc was a trade of 22,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 25, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Spruce Biosciences Inc | Dina Chaya | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2022 | 22,500 | 22,500 | - | - | Stock Option (Right to Buy) | |
| Spruce Biosciences Inc | Dina Chaya | Director | 14 Oct 2020 | 12,500,000 | 0 | - | - | Series B Preferred Stock | ||
| Spruce Biosciences Inc | Dina Chaya | Director | 14 Oct 2020 | 1,911,022 | 1,911,022 | - | - | Common Stock | ||
| Spruce Biosciences Inc | Dina Chaya | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 14 Oct 2020 | 250,000 | 2,161,022 | - | 15 | 3,750,000 | Common Stock |